Waldencast plc Class A Ordinary Share (WALD) Dividend History

Company News

• Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand

  Waldencast has acquired Novaestiq Corp. and the U.S. rights to the Saypha® injectable hyaluronic acid gel line, expanding Obagi Medical's portfolio into dermal fillers and positioning the company at the intersection of skincare and aesthetic treatments.

  Benzinga
• Waldencast Announces Participation in the 2025 IMCAS World Congress

  Waldencast, a global multi-brand beauty and wellness platform, announced its participation in the 2025 IMCAS World Congress in Paris. The company's founder and CEO, as well as the Chief Medical Director of Obagi Medical, will be speaking at the event.

  GlobeNewswire Inc.
• Can Waldencast PLC (WALD) Climb 26% to Reach the Level Wall Street Analysts Expect?

  The consensus price target hints at a 26% upside potential for Waldencast PLC (WALD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

  Zacks Investment Research
• Stocks To Watch: Apple, Amazon, Microsoft And Meta Platforms Headline Huge Week Of Earnings

  Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week

  Seeking Alpha

  Featured Companies: ATER BEAM BMY BROS BYND CRDO CTAS KSCP LWLG REE WHR WING ZENV